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Abstract
The PET Centre Prague (www.homolka.cz/nm) was established
in 1999 as the outcome of a joint project of the public Na Ho-
molce Hospital and the Nuclear Research Institute Re, plc, the
Czech radiopharmaceutical producer. Technical and financial
assistance was provided by the International Atomic Energy
Agency, which perceived the Centre as its model project that
could serve as a guide for the development of PET centres in
countries sharing a comparable level of development with the
Czech Republic. The article maps the history of the project, its
design, workplace lay-out and equipment, radiation protection
arrangements and spectrum of the first approx. 3,000 investi-
gations.
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History
During the last quarter of a century there has been at first slow,
then tentative, and finally amazingly dynamic development of
positron emission tomography (PET). The idea of setting up a PET
centre on the territory of what is today the Czech Republic had
been expressed in the past, but until then the only successful ini-
tiative had come from Czech radiopharmaceutical producer Nu-
clear Research Institute Re, plc (NRI). In 1996 the project was
given support by the Ministry of Health and the State Office for
Nuclear Safety. Significant help, both financial and technical, was
extended by the International Atomic Energy Agency (IAEA) as
part of its technical co-operation programme. IAEA perceived the
development of a PET centre in the Czech Republic as a model
project [1] that could serve as an example and source of informa-
tion for developing PET centres in countries that had achieved
a comparable stage of development.
The implementation of the model project started in 1997 by
seeking the best location for the PET Centre. The first three-quar-
ters of 1998 were devoted to the preparation of project documenta-
tion and acquisition of the necessary permits; building work started
in the last part of the year. The construction was completed in the
middle of the following year and had a certificate of occupancy
issued; the separate building (Fig. 1) on the premises of the Na
Homolce Hospital (Fig. 2) then started performing some of its
planned activities. The first PET scan in the Czech Republic was
performed on August 25, 1999, using 2-[18F] fluoro-D-glucose (FDG).
FDG cannot be mentioned without remembering Josef PacÆk
and his colleagues. They had been the first in the world to create
a non-active form of this molecule in 1968 in Prague [2]. Thirty
years later, in Toronto, FDG was nominated nuclear medicine
molecule of the century by Prof. Henry N. Wagner Jr.
Maybe we should explain why the PET Centre started by offer-
ing only a part of its planned services. That is connected with
FDG too. FDG was of course produced from the time when all the
technology was installed in 1999  not however as a radiophar-
maceutical, but as a radiochemical. It is necessary to be aware of
the enormous difference between these two seemingly similar
concepts. Much additional time was needed to perform the vali-
dation of all the production processes and to acquire the permits
necessary for the production of pharmaceuticals in the new faci-
lity. FDG properties had to be established, clinical trials of the prep-
aration approved, evaluation of the effect on volunteers performed.
Finally, the process culminated in the issuing of the registration
decree. All this took another two years, which meant that the dis-
tribution of FDG for human application started from the middle of
October 2001.
Almost 2,700 PET scans could be performed in this interim
period, only thanks to the availability of an alternative source of
FDG at the Nuclear Physics Institute of the Academy of Sciences
of the Czech Republic, which is located at a distance of 40 minutes
by car. The production of FDG had started some time earlier at this
Institute and had been designated originally for two Prague cen-
tres equipped with high energy collimators suitable for SPECT
investigation of myocardial viability.
Design and lay-out
The PET Centre Prague was designed to house a satellite
positron emission tomography system. The twice-daily produc-
tion of 60 GBq FDG provides for both the supply of the local cen-
tre and for distribution within a reasonable transporting distance
(the half-life period of 18F is 110 minutes). The current double-
storey building of the PET Centre has been converted from a stor-
age building. The ground floor is the production area and is whol-
ly managed by NRI. The second floor is occupied by the nuclear
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medicine out-patients department of the Na Homolce Hospital.
Having separate outside entrances to both floors is a convenient
arrangement for the co-existence of two different entities.
The production area complies with the established practice of
containing a restricted zone with ventilation-controlled negative
pressure. The clean areas are inside the controlled zone. The
prescribed purity of the environment is controlled by positive pres-
sure ventilation using HEPA filters and by a number of other nec-
essary arrangements. In the clean areas there are also rooms
dedicated to the preparation of radiopharmaceuticals for conven-
tional scintigraphy (Fig. 3).
The second floor is divided longitudinally into three indepen-
dent yet communicating compartments: waiting room, technolo-
gy, staff-rooms (Fig. 4). The arrangement provides the greatest
possible radiation protection, reflects the sequence of individual
operations and also observes a certain degree of separation of
workers, without however compromising their co-operation. For
a number of reasons, the department has been designed to func-
tion as a joint PET and conventional scintigraphy work-place.
Along the southern wall there is a common waiting room with
entrances leading to the camera rooms and rooms for intrave-
nous administration of radiopharmaceuticals. The long waiting area
is designed to present minimal danger of patients irradiating one
another. There is a small attached yet separated waiting room for
severely ill patients or small children. At the entrance there is an
open desk adjacent to the archive and office. The receptionist is
shielded by a concrete-filled counter (Fig. 5).
All the four camera rooms are in the interior of the building,
protecting instruments from temperature swings. Together with
rooms for radiopharmaceutical administration they are located
within the controlled zone. This zone is interconnected and linked
to the sanitary loop. Radiopharmaceuticals are delivered from the
ground floor by a small lift. Moreover a shielded capillary is pre-
pared for transport of 15O oxygen (half-time period 2.1 minutes)
straight from the cyclotron into the PET camera room. All camera
and administration rooms are connected with the control room,
the common work-place of the technologists, where acquisition
consoles are located. This layout ensures high radiation protec-
tion of the staff, viewing the patients through leaded windows and
enables collaboration between the technologists.
In the neighbourhood of this work centre there is a report room
in which physicians evaluate images at other consoles. The ar-
rangement allows for contact between the physicians and the tech-
nologists while providing the privacy needed for concentration.
All these areas are accessible to the staff from the corridor, so
staff and patients do not cross one anothers paths. The corridor
also links offices, coffee room and cloakroom.
Equipment
The heart of the PET Centre is the Belgian IBA Cyclone 18/9
cyclotron (Fig. 6). The produced radionuclide flows from the cy-
clotron through capillaries into Variotec (a Czech producer) cham-
bers, shielded by 10 cm of lead, which contain the synthetisation
computer-controlled modules. The FDG-producing module is
a Nuclear Interface product (Germany). The clean area contains
boxes with laminary air flow of < 1 microbe per 1 m3 purity; the
boxes and the clean area technology were supplied by a Czech
company, Labox. Also on the ground floor there are three large
liquid-waste tanks working in alternating regimes  one tank fills
while the activity in the second decays to a release level; the third
tank is the reserve. The whole required range of laboratory instru-
ments for product quality control is available. The sophisticated
ventilation and cooling technology, together with a large number
of regulatory, control and security systems, preventing, for exam-
ple, radioactive leakage into the atmosphere, makes this a very
complex installation.
The clinical part is equipped with a CTI/Siemens ECAT EXACT
PET scanner (Fig. 7) and a modern double-head Siemens E.CAM
scintigraphic camera allowing transmission attenuation correction.
Also available is an old Philips camera which, however, is used
only exceptionally as an operative reserve. One of the examining
rooms has been designed as a reserve for the installation of
a second PET camera.
Besides single-purpose evaluation consoles the department
has two universal (Nuclear Diagnostics) computers providing ful-
ly automated archiving of scanned studies and all-round analy-
ses and viewing of nuclear medicine data. The installed system
[3] has the properties of PACS systems. An advantage is the pos-
sibility of viewing and of processing basic data by remote access,
which opens up telemedical prospects. Moreover, these comput-
ers interconnect the camera consoles with the departments infor-
mation system. Thus the identity of patients needs to be recorded
only once when their appointment is made; after that the only thing
that needs to be done is to make the selection from the menu
 this can be done also at the acquisition consoles. The advanced
information system [3] provides flexible support to all the activi-
ties of the department and it communicates with the hospital in-
formation system. It exceeds the properties of commercially avail-
able radiological information systems (RIS).
Radiation protection
Although the radioactivity applied during PET (approx. 500 MBq) is
similar to that applied in common scintigraphy, the radiation load
on staff is incomparably larger. This is due to the emission of two
photons instead of one, to the higher total amount of processed
activity due to the shorter half-life period and high penetration. It is
not easy to shield high-energy 511 keV radiation. Experience has
shown that an approx. 6-cm-thick lead shield is required to shield
radiopharmaceuticals used for four PET scans. The tungsten cover
of the syringe shields only 2.5 times at 0.8 kg of weight!
There is a number of PET centres that scan 800 to 1,000 pa-
tients annually. In these cases the radiation load of the staff is not
a severe problem. In the case of the PET Centre in Prague, two-
shift operations have been introduced (two FDG supplies daily,
up to 10 patients in one day). Besides staff rotation and distance
protection, increased attention has been paid to shielding. The
walls are covered on both sides by a 2 · 5-cm-thick layer of bary-
ta plaster. A special and powerful shielding has been developed
for the storage of active vials and for the subsequent filling of
syringes [4]. Another useful aid is the PETmobile  a comfort-
ably controlled vehicle for the transport of the fully shielded sy-
ringe to the patient.
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Figure 1. Building of the PET Centre in Prague (opposite the main hospi-
tal building).
Figure 2. Main building of the Na Homolce Hospital (opposite the build-
ing of the PET Centre).
Figure 3. Clean area:
Preparation of 99mTc labelled
radiopharmaceuticals.
Figure 4. Outpatient room layout. Green: patient area; red: controlled
zone; blue: staff area.
Figure 5. Entrance area. The receptionist is shielded by a concrete-filled
counter.
Figure 6. Cyclotron IBA, model Cyclone 18/9.
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Operations
The regular delivery of 5 GBq FDG on every working day morn-
ing started on August 25, 1999. Until the end of that year the very
expensive investigation was neither covered by health insurance
nor reimbursed by payments from patients. Intensive negotiations
resulted in the approval of the reimbursement from January 1,
2000 of the full cost from mandatory health insurance. Since ev-
ery citizen of the Czech Republic must be insured, the investiga-
tion is available to all citizens free of charge. Since autumn 2000,
FDG have been delivered also in the afternoons, which has result-
ed in an increase in the number of investigations (Fig. 8).
The oncological investigations of the torso are the most fre-
quent type of PET scans (82%). The range of oncological reasons
for PET is shown on Figure 9. Brain PET (15%) comprises predom-
inantly investigations for epilepsy and tumours due to the speciali-
Figure 7. PET scanner CTI, model ECAT EXACT.
Figure 8. Number of PET scans performed per quarter of years. Opera-
tion started on August 25, 1999. Clearly apparent is the positive effect of
the second shift (IV.Q/2000) and the negative effect of the holiday period
(III.Q).
Figure 10. Patient with history of colorectal cancer is presented. Tumour recurrence is con-
sidered due to continuously growing CEA blood levels. All conventional investigations of the
abdomen were negative. FDG-PET was also negative in the region of abdomen. Thanks to
long field of view, PET enabled discovery of latent thyroid cancer duplicity in the time of no
clinical signs.
Figure 9. Frequency of reasons for oncological torso PET scan during
last 12 months.
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sation of the Na Homolce Hospital. Myocardial viability investiga-
tions represent 3% only, since this can be investigated also at other
Prague centres using FDG-SPECT. The investigations are performed
only in cases indicated by the referring doctor. The suitability of
indication is first consulted with PET Centre specialists. The waiting
list has so far been kept to one to three weeks. However, increasing
awareness among doctors of the method leads to a continuously
growing interest and it is clear that the only solution would be the
installation of the second scanner.
Conclusion
The PET Centre Prague became a reality as a model project
thanks to the co-operation between the Na Homolce Hospital and
NRI, and also to the technical and financial assistance from IAEA.
The Centre provides a dignified environment for patients and also
offers convenient working conditions for the staff. The modern
technology applied and the experience of more than 3,000 per-
formed PET investigations is a good basis for high quality diag-
nostics. The results of the studies performed so far
(www.homolka.cz/nm/odb/publikace-e.html) testify to the achieve-
ment of diagnostic parameters comparable with literary data. A very
important circumstance is the fact that PET investigations are fully
covered by medical insurance.
PET today is no longer the cream at the top of nuclear medi-
cine, accessible only to large universities in the technologically
most advanced countries. PET has become a clinical tool which
ought to be available in all countries where, for instance, chemo-
therapy is commonly administered to cancer patients. The price
of one PET investigation is in fact comparable with the price of
a single cycle of chemotherapy, and the rational application of the
method leads both to the improvement of the health status of the
individual patient (Fig. 10) and, eventually, to savings in national
health care.
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